3His L, Xi X, l.otan R, et al. The histone deacetylase inhibitor suberoylanilide hydroxaraic acid induces apoptosis via induction of 15-1ipoxygenase-1 in colorectal cancer cells[J]. Cancer Res, 2004,64(23):8778-8781.
4Mariadason JM. HDACs and HDAC EJ. Epigenetics,2008,3(1):28-37. Hanahan D,Weinberg R. Hallmarks 144(5)..646 674.
5inhibitors in colon cancer of cancerEJ]. Ce11,2011.144(5):646 674.
6Kouraklis G, Misiakos EP,Theocharis S. Histone deacetylase in- hibitors as a potential therapeutic agent for human cancer treat- mentEJ. Targ Oncol,2006,1(1):34 41.
7Suzuki T,Ando T,Tsuchiya K,et aL Synthesis and histone deacety- lase inhibitory activity of new benzamide derivatives J. J Med Chem,1999,42(15) :3001 3003.
8Vigushin D,Coombes R. Targeted histone deacetylase inhibition for cancer therapyEJ. Curr Cancer Drug Targets, 2004,4(2): 205-218.
9Saito A, Yamashita T, Mariko Y, et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors J]. Proc Natl Acad Sci USA, 1999,96 (8) :4592-4597.
10Sakajiri S, Kumagai T, Kawamata N, et al. Histone deacetylase inhibitors pro{oundly decrease proliferation of human lymphoid cancer cell lines[J]. Exp Hem atol, 2005,33 (1) : 53-61.
